Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Alanine aminotransferase increased
ADR ID BADD_A00134
ADR Hierarchy
13      Investigations
13.03      Hepatobiliary investigations
13.03.01      Liver function analyses
13.03.01.003      Alanine aminotransferase increased
Description A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen. [CTCAE]
MedDRA Code 10001551
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Alanine aminotransferase increase | Alanine aminotransferase increased | ALT increased | Glutamic-pyruvate transaminase increased | Glutamic-pyruvic transam incr | Glutamic-pyruvic transaminase increased | GPT inc | GPT increased | GPT increased transient | Serum glutamic-pyruvic ta incr | Serum glutamic-pyruvic transaminase increased | SGPT increased | Transaminase glutamic-pyruvic increased | Serum glutamic-pyruvic ta increased | ALT flare up | ALT high
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02436Atorvastatin--
BADD_D02438Enoxaparin0.004197%
BADD_D02458Glycine betaine0.097284%
BADD_D02459Dalteparin0.038113%
BADD_D02463Pitavastatin0.003712%
BADD_D02464Fingolimod0.303971%
BADD_D02470Nintedanib0.002398%
BADD_D02477Tenofovir alafenamide0.005787%
BADD_D02483Ribociclib0.003463%
BADD_D02486Niraparib0.000799%
BADD_D02487Baricitinib0.001158%
BADD_D02489Neratinib0.000799%
BADD_D02504Lorlatinib0.000799%
BADD_D02509Brigatinib0.000533%
BADD_D02510Rucaparib0.010390%
BADD_D02515Pexidartinib0.001865%
BADD_D02520Baloxavir marboxil0.002170%
The 21th Page    First    Pre   21    Total 21 Pages